These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 15207426

  • 21. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [Abstract] [Full Text] [Related]

  • 22. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ.
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study.
    Borgemeester RWK, van Laar T.
    Parkinsonism Relat Disord; 2017 Dec; 45():33-38. PubMed ID: 29032012
    [Abstract] [Full Text] [Related]

  • 25. Continuous dopaminergic stimulation--from theory to clinical practice.
    Antonini A.
    Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S24-8. PubMed ID: 17702632
    [Abstract] [Full Text] [Related]

  • 26. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.
    Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA.
    Brain; 2005 Mar; 128(Pt 3):570-83. PubMed ID: 15689366
    [Abstract] [Full Text] [Related]

  • 27. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW.
    Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220
    [Abstract] [Full Text] [Related]

  • 28. Effect of subcutaneous apomorphine on tremor in idiopathic Parkinson's disease.
    Hellmann MA, Sabach T, Melamed E, Djaldetti R.
    Biomed Pharmacother; 2008 Nov; 62(4):250-2. PubMed ID: 17967525
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Apomorphine in treatment of Parkinson's disease with fluctuations].
    Zaleska B, Domzał T.
    Neurol Neurochir Pol; 1999 Nov; 33(6):1297-303. PubMed ID: 10791032
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine].
    Merello M, Leiguarda R.
    Medicina (B Aires); 1995 Nov; 55(1):5-10. PubMed ID: 7565037
    [Abstract] [Full Text] [Related]

  • 36. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B, Angersbach D, Jost WH.
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [Abstract] [Full Text] [Related]

  • 37. Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease.
    Pfeiffer RF, Gutmann L, Hull KL, Bottini PB, Sherry JH, APO302 Study Investigators.
    Parkinsonism Relat Disord; 2007 Mar; 13(2):93-100. PubMed ID: 17055329
    [Abstract] [Full Text] [Related]

  • 38. Dopamine agonists in the treatment of Parkinson's disease.
    Bonuccelli U, Pavese N.
    Expert Rev Neurother; 2006 Jan; 6(1):81-9. PubMed ID: 16466315
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson's disease.
    Grandas F.
    Expert Rev Neurother; 2013 Dec; 13(12):1343-53. PubMed ID: 24160681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.